Robotic VR System to Teleoperate Robots for Performing COVID-19 Swab Tests
|
By LabMedica International staff writers Posted on 23 Feb 2022 |

A newly-developed robotic virtual reality (VR) human-machine interface (HMI) system can teleoperate the robot to imitate the user's actions to perform complicated tasks such as COVID-19 swab tests.
A research team co-led by City University of Hong Kong (CityU Hong Kong) has developed an innovative HMI system, which consists of flexible, multi-layered electronic skin and provides both visual and haptic feedback to users. The system can teleoperate the robot to imitate the user's actions to perform complicated tasks. It demonstrates the potential for conducting COVID-19 swab tests and nursing patients with infectious diseases.
The HMI system links users to robotics or computers and plays a significant role in teleoperating robotics. However, conventional HMIs are based on bulky, rigid and expensive machines, and the lack of adequate feedback to users limits their application for conducting complicated tasks. The closed-loop HMI system is based on soft, skin-integrated electronics, which enable wireless motion capture and haptic feedback via Bluetooth, Wi-Fi and the internet.
The advanced HMI system, named Robotic VR, is an integration of visual, auditory and haptic VR via skin-integrated electronics. It uses a layout of multilayer stacking, where the bottom layer of skin-tone elastomeric silicon serves as a soft adhesive interface, which can be mounted on the skin and joints of the user. The layers are interconnected with a collection of chip-scale integrated circuits and sensing components, including resistors, capacitors, a Bluetooth module, a microcontroller unit (MCU), and soft sensors and actuators developed by the team.
The sensors of the robotic VR system can accurately detect and convert subtle human motion into electrical signals, which are processed by the MCU and wirelessly transmitted to the target robot. In this way, the user can teleoperate the robot to imitate his motion to accomplish tasks remotely. The pressure sensors on the robot can send feedback signals to control the vibration intensity of the haptic actuators through the Bluetooth module, thus providing haptic feedback to the user. The user can then precisely control and adjust the motion of the robot’s arm according to the intensity of the feedback.
The HMI system supports three wireless transmission methods – Bluetooth (up to tens of meters), Wi-Fi (up to about 100 meters), and the Internet (worldwide) – which can be adjusted according to the practical applications. The new system is stretchable and can be tightly mounted on human skin and even the whole human body for a long time. In addition, the interface provides both haptic and visual feedback systems, providing an immersive experience for users. The HMIs could teleoperate various machines. With the advanced circuit design and outstanding mechanical characteristics, the newly invented HMI system has great potential for applications in commercial and biomedical engineering fields. For example, it can be used to remotely drive unmanned cars. A user with a hand disability can remotely manipulate a robot to carry heavy goods using the HMI system. The sensors attached to the user can monitor and transmit muscle signals to control the robot.
On the biomedical engineering side, doctors can remotely control robots to conduct surgery by wearing the HMI system with VR glasses. And medical workers can remotely manipulate the robot to look after infectious patients or collecting bio-samples, thus greatly decreasing the infection risk. The team conducted experiments to demonstrate the system's potential applications, such as remotely controlling the robotic hand to collect throat swab samples for COVID-19 tests, and to teleoperate humanoid robots to clean a room and even provide patient care. The team is developing a next-generation system to provide the robotic collection of swab tests. The researchers expect the new-generation HMI system to help provide a new approach in wirelessly connecting people to a robot or virtual character in the metaverse.
“This new-generation flexible human-machine interface system enables teleoperating robotics for conducting complicated tasks,” said Dr. Yu Xinge, Associate Professor in the Department of Biomedical Engineering (BME) at CityU.
Related Links:
City University of Hong Kong
Latest COVID-19 News
- New Immunosensor Paves Way to Rapid POC Testing for COVID-19 and Emerging Infectious Diseases
- Long COVID Etiologies Found in Acute Infection Blood Samples
- Novel Device Detects COVID-19 Antibodies in Five Minutes
- CRISPR-Powered COVID-19 Test Detects SARS-CoV-2 in 30 Minutes Using Gene Scissors
- Gut Microbiome Dysbiosis Linked to COVID-19
- Novel SARS CoV-2 Rapid Antigen Test Validated for Diagnostic Accuracy
- New COVID + Flu + R.S.V. Test to Help Prepare for `Tripledemic`
- AI Takes Guesswork Out Of Lateral Flow Testing
- Fastest Ever SARS-CoV-2 Antigen Test Designed for Non-Invasive COVID-19 Testing in Any Setting
- Rapid Antigen Tests Detect Omicron, Delta SARS-CoV-2 Variants
- Health Care Professionals Showed Increased Interest in POC Technologies During Pandemic, Finds Study
- Set Up Reserve Lab Capacity Now for Faster Response to Next Pandemic, Say Researchers
- Blood Test Performed During Initial Infection Predicts Long COVID Risk
- Low-Cost COVID-19 Testing Platform Combines Sensitivity of PCR and Speed of Antigen Tests
- Finger-Prick Blood Test Identifies Immunity to COVID-19
- Quick Test Kit Determines Immunity Against COVID-19 and Its Variants
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more








